Joseph P. Lucia & Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,505
Closed -$139K 170
2022
Q2
$139K Sell
1,505
-1,265
-46% -$123K 0.1% 126
2022
Q1
$280K Sell
2,770
-1,862
-40% -$196K 0.17% 91
2021
Q4
$478K Sell
4,632
-1,452
-24% -$134K 0.3% 73
2021
Q3
$516K Sell
6,084
-123
-2% -$10.3K 0.31% 78
2021
Q2
$518K Buy
6,207
+702
+13% +$57.5K 0.31% 77
2021
Q1
$414K Buy
5,505
+315
+6% +$22.9K 0.18% 83
2020
Q4
$354K Buy
+5,190
New +$338K 0.25% 81
2020
Q3
Sell
-24
Closed -$2K 157
2020
Q2
$2K Buy
+24
New +$1.51K ﹤0.01% 430
2020
Q1
Sell
-47
Closed -$3K 455
2019
Q4
$3K Hold
47
﹤0.01% 389
2019
Q3
$3K Sell
47
-17
-27% -$1.01K ﹤0.01% 389
2019
Q2
$3K Sell
64
-856
-93% -$46.1K ﹤0.01% 388
2019
Q1
$17 Buy
+920
New +$56.8K ﹤0.01% 325

Other funds holding CVS

Joseph P. Lucia & Associates's CVS Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of CVS Health (CVS) in Q3 2022, closing a stake of 1,505 shares — an estimated $139K sold.

Joseph P. Lucia & Associates first reported a position in CVS in Q1 2019 and held it in 12 quarters. The position peaked at $518K in Q2 2021. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Joseph P. Lucia & Associates reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 1,505 CVS Health shares in Q3 2022, an estimated $139K.
  • Joseph P. Lucia & Associates first reported a position in CVS Health in Q1 2019 and held it in 12 quarters.
  • Joseph P. Lucia & Associates's CVS Health position peaked at $518K in Q2 2021.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.